| # | Drug | Count |
|---|---|---|
| 0 | TEDUGLUTIDE | 55 |
| 1 | ADALIMUMAB | 42 |
| 2 | CARBIDOPA AND LEVODOPA | 28 |
| 3 | ADALIMUMAB-AATY | 24 |
| 4 | ADALIMUMAB-ADAZ | 24 |
| 5 | ADALIMUMAB-FKJP | 24 |
| 6 | VEDOLIZUMAB | 24 |
| 7 | METHOTREXATE | 23 |
| 8 | METHOTREXATE SODIUM | 23 |
| 9 | USTEKINUMAB | 22 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TEDUGLUTIDE | 55 | 0.0041 |
| 1 | 1169 HYDROGEN PEROXIDE SPRAY | 1 | 0.0032 |
| 2 | HYDROGEN PEROXIDE | 1 | 0.0030 |
| 3 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 1 | 0.0021 |
| 4 | SAFINAMIDE MESYLATE | 2 | 0.0014 |
| 5 | I. V. FAT EMULSION | 1 | 0.0014 |
| 6 | CARBIDOPA LEVODOPA | 4 | 0.0011 |
| 7 | AMANTADINE | 9 | 0.0007 |
| 8 | MIDODRINE HYDROCHLORIDE | 3 | 0.0007 |
| 9 | CARBIDOPA AND LEVODOPA | 28 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | GLP-2 Analog [EPC] | 55 |
| 1 | Aromatic Amino Acid [EPC] | 34 |
| 2 | Corticosteroid [EPC] | 30 |
| 3 | Interleukin-23 Antagonist [EPC] | 30 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 27 |
| 5 | Integrin Receptor Antagonist [EPC] | 24 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 23 |
| 7 | Interleukin-12 Antagonist [EPC] | 22 |
| 8 | Benzodiazepine [EPC] | 15 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | GLP-2 Analog [EPC] | 55 | 0.0041 |
| 1 | Serotonin-4 Receptor Agonist [EPC] | 1 | 0.0015 |
| 2 | Nonergot Dopamine Agonist [EPC] | 10 | 0.0006 |
| 3 | Catechol-O-Methyltransferase Inhibitor [EPC] | 3 | 0.0006 |
| 4 | Influenza A M2 Protein Inhibitor [EPC] | 9 | 0.0006 |
| 5 | Aromatic Amino Acid [EPC] | 34 | 0.0006 |
| 6 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 7 | Lipid Emulsion [EPC] | 1 | 0.0004 |
| 8 | Aromatic Amino Acid Decarboxylation Inhibitor [EPC] | 10 | 0.0004 |
| 9 | Monoamine Oxidase Inhibitor [EPC] | 1 | 0.0003 |